Scotti, Celeste <br/><br/>
Response of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1β and low oxygen.  [electronic resource] 

 -  Tissue engineering. Part A  Feb 2012 
 - 362-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1937-335X 
<br/><br/><label>Standard No.: </label>10.1089/ten.TEA.2011.0234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cartilage Oligomeric Matrix Protein<br/>Cartilage, Articular--cytology<br/>Cells, Cultured<br/>Chondrocytes--cytology<br/>Collagen Type II--metabolism<br/>Epitopes--metabolism<br/>Extracellular Matrix Proteins--metabolism<br/>Female<br/>Glycoproteins--metabolism<br/>Glycosaminoglycans--metabolism<br/>Humans<br/>Interleukin-1beta--pharmacology<br/>Male<br/>Matrilin Proteins<br/>Matrix Metalloproteinases--metabolism<br/>Middle Aged<br/>Nose--cytology<br/>Oxygen--pharmacology<br/>Tissue Engineering--methods<br/>Tissue Scaffolds--chemistry